
Terremotobio
By unleashing the power of covalent chemistry, we can deliver superior small molecule medicines with enhanced therapeutic benefit.
Series B+ ·
Amount not disclosed in a source on record.
Funding history ↓Signals
Website registeredAug 12, 2021 (5 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | undisclosed | — | fundraisingfox.com |
Timeline
- Website created
Founders and team
- PTPeter Thompson Co-founder and Directorsource: terremotobio.com
Companies like Terremotobio
MMatchpoint Therapeutics$150M Series B+ · Oct 2026
TTotus Medicines$66M Series B+ · Dec 2023
NNoema PharmaSeries B+ · Nov 2025
MModel Medicines$4.1M · Nov 2021
RRgenta TherapeuticsSeries B+ · Nov 2026
EEnveda$311M Series B+ · Sep 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/terremotobio (get a free API key).